Abstract
Introduction
Numerous studies have implicated that the immune system plays a major role in arteriogenesis [1, 2] . A specific cell of the immune system, the regulatory T cell (CD4 ϩ CD25 ϩ FoxP3 ϩ [3, 4] and are indispensable for balancing immune responses [5, 6] . Accumulating evidence suggests an important role of regulatory T cells in the control of atherosclerotic lesion development and progression [7] [8] [9] . Recently, Zouggari et al. [10] [8, [10] [11] [12] [13] . [10] . [10, 15] to increase regulatory T cells [15] . [7, 16] , but also affects activated T cells [17] , dendritic cells (DCs) [18] and natural killer (NK) cells [19] . Recently, a more powerful approach to fully deplete regulatory T cells was described by Lahl et al. [20] . [21] 
T cell), is specialized in the suppression of effector T-cell pathogenic immune responses. Regulatory T cells control T-cell homeostasis

assessed for the first time the role of regulatory T cells on blood flow recovery after ischemia induction in mouse models with a reduced regulatory T cell number and function
They reported a key role of regulatory T cells in post-ischemic neovascularization. Post-ischemic blood flow recovery was significantly enhanced in these mice up to 70% 21 days after ischemia induction as compared to slow recovery in control mice
Because the mouse models used for depletion of regulatory T cells may also show effect on other T cell subtypes besides the regulatory T cell [14], a more detailed and specific analysis of the role of the regulatory T cell in arteriogenesis is required. The question remains how regulatory T cells regulate arteriogenesis and moreover whether regulatory T cell expansion has effects on arteriogenesis. The effect of expanding regulatory T cell number on arteriogenesis can be studied using the recently described method for in vivo expansion of regulatory T cells by Webster et al. [15] Injecting mice with a complex of interleukin (IL)-2 mixed with JES6-1 IL-2 monoclonal antibody (mAB) led to a marked increase in regulatory T cell number. This approach caused selective expansion of regulatory T cells with little or no change in other cells, making it superior to other attempts
Next to expansion of regulatory T cell number, depletion of regulatory T cells is highly informative. The standard approach is depletion of CD25 ϩ cells. But this approach has its shortcomings because anti-CD25 treatment does not result in a selectively depletion of regulatory T cells only
Material and methods
Experimental animals
Modulation of regulatory T cell levels
Regulatory T cell expansion
Regulatory T-cell depletion
Depletion of regulatory T cells is accomplished by treating C57Bl6 mice with CD25-depleting PC61 antibody
Flow cytometry
Cells were labelled with fluorescein isothiocyanate (FITC) anti-CD4 (eBioscience) and Allophycocyanin (APC) anti-CD25. An intracellular FoxP3 staining was performed with PE anti-FoxP3 (eBioscience). Regulatory T cell labelling was analysed by flow cytometry on a LSRII FACS apparatus (Becton Dickinson B.V., Breda, the Netherlands) and analysed with BD FACS DIVA software.
In vitro suppression assay
Peripheral lymph nodes were removed from three DEREG mice after repetitive DT injections during 3 weeks and in three DEREG mice without DT injections. The functional suppression assay was performed as described by Rausch et al. [24] . (Fig. 1A) . Mice treated with injections of IL-2-mAB complex (n ϭ 10) showed significant attenuated blood flow recovery up to 20% at days 7 and 14 after ischemia compared to controls (n ϭ 10), indicating that an increase in regulatory T cell number was responsible for a suppression in blood flow recovery after hind limb ischemia (Fig. 1B) . Furthermore, mice treated with IL-2-mAB complex showed a significant lower number of ␣-SMAexpressing collaterals in the post-ischemic adductor muscle as compared to controls (Fig. 1C) . [25, 26] . No effect of anti-CD25 antibody treatment (n ϭ 10) on blood flow recovery was observed as compared to controls (n ϭ 10) after single electro-coagulation of the artery (Fig. 2A) .
Statistical analysis
Results are expressed as mean Ϯ S.E.M. Comparisons between means were performed with an independent t-test. P-values
Results
Expansion of regulatory T cells results in impaired post-ischemic blood flow recovery The effect of expanding regulatory T cells on arteriogenesis in mice is unknown. Regulatory T cell numbers were expanded in the hind limb ischemia mouse model by injecting mice with IL-2 mixed with an IL-2 mAB. Injections of IL-2-mAB complex led to a 2-fold expansion of regulatory T cells in the peripheral blood
Decline of regulatory T cells using anti-CD25 did not show any effect on blood flow recovery Next to expansion of regulatory T cells, we were interested in the effects of regulatory T cell depletion too. Originally, regulatory T cells were identified by the expression of CD25 and numerous in vivo experiments studying regulatory T cells have been performed with depleting antibodies directed against CD25
The moderate effects of the depletion on arteriogenesis could be obscured by the rapid response of these mice. Although the therapeutic window was increased after double electrocoagulation of both the femoral artery and iliac artery, CD25
depleting antibody-injections (n ϭ 10) did not result in any alteration of blood flow recovery as compared to controls (n ϭ 10) (Fig. 2B) . FACS analyses showed 87% depletion of regulatory T cells directly after the surgical procedure. However, regulatory T cell levels returned to half of normal levels 1 week after ischemia, but at that moment, again anti-CD25 was injected into these mice (Fig. 2C) (Fig. S1) . (Fig. 3E) (Fig. 4B) . Fig. 2 (A [10] . For modulation of regulatory T cell content, more specific approaches were used for a major expansion or complete depletion of regulatory T cells. [15] . In the present study, expansion of regulatory T cells resulted in an attenuated blood flow recovery after ischemia induction. Up to 20% suppression of blood flow at day 14 after ischemia induction was observed. These results are in contrast to the major effects of application of this IL-2-mAB complex in various autoimmune disease mouse models, which resulted in the expansion of regulatory T cells in mice leading to a strong resistance to T cell mediated autoimmune disease [15] .
On the tissue level, regulatory T-cell-depleted DEREG mice showed a significant increase of SMA-expressing collateral density in the post-ischemic adductor muscle
Images on the right depict representative LDPI images of paws of mice injected with PBS (upper) or IL-2-mAB complex (lower) at 14 days after induction of hind limb ischemia. (C) Histograms depict mean Ϯ S.E.M. of the number of collaterals in the post-ischemic adductor muscle as quantified by SMA labelling (nine sections per muscle were analysed in five animals/ treatment group). *P Ͻ 0.05. Representative photographs of SMA labelling are shown 14 days after hind limb ischemia induction in mice treated with PBS (left) and IL-2 mAB (right). Magnification: 10ϫ. (D) The histogram depicts mean Ϯ S.E.M. of the number of capillaries in the post
Discussion
In the present study, the contribution of regulatory T cells to the arteriogenic response was studied by analysing the effects of modulation of regulatory T cell levels on arteriogenesis in a mouse
Expansion of regulatory T cells was induced by injecting mice with IL-2 mixed with the JES6-1 IL-2 mAB [15]. Unlike most IL-2 mABs, injections of this IL-2-mAB complex led to selective proliferation of regulatory T cells with little or no change in other inflammatory cells making the IL-2-mAB complex superior to other interventions
In addition to regulatory T cell expansion, we studied the effects of depletion of regulatory T cells on arteriogenesis. Depletion of CD25
ϩ cells with injections of anti-CD25 antibody did not result in any alteration of post-ischemic blood flow recovery as compared to controls. Zouggari et al. [10] did report significant improved blood [8, [10] [11] [12] [13] . However, CD28 is the major B7-binding costimulatory [14] . [7] . Although depletion is limited and far from complete, mice vaccinated against FoxP3 showed a significant 34% increase in plaque size as compared to controls [7] .
receptor on T cells and is critical for T cell responses in vivo
In conclusion, the present study demonstrates that regulatory T cells do contribute to the regulation of post-ischemic neovascularization. However, only moderate effects on post-ischemic neovasculzarization were observed after major modulations of regulatory T cell number.
